We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.29%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$43.8B
AUM Growth
+$2.95B
(+7.2%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
6.68%
Top 10 Holdings %
Top 10 Hldgs %
29.71%
Holding
2,321
New
255
Increased
1,689
Reduced
325
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$408M |
| 2 |
NVIDIA
NVDA
|
+$395M |
| 3 |
Microsoft
MSFT
|
+$382M |
| 4 |
Amazon
AMZN
|
+$253M |
| 5 |
Palantir
PLTR
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$285M |
| 2 |
NextEra Energy
NEE
|
+$207M |
| 3 |
West Pharmaceutical
WST
|
+$168M |
| 4 |
Broadcom
AVGO
|
+$133M |
| 5 |
Meta Platforms (Facebook)
META
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.42% |
| 2 | Consumer Discretionary | 10.78% |
| 3 | Consumer Staples | 10.15% |
| 4 | Industrials | 10.05% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Standard BioTools
LAB
$326M
| $145K | ﹤0.01% |
83,074
+27,334
| +49% | +$50.9K |
|
1977
Zevra Therapeutics
ZVRA
$563M
| $145K | ﹤0.01% |
+17,425
| New | +$149K |
|
|
INVX
1978
Innovex International
INVX
$1.87B
| $145K | ﹤0.01% |
+10,376
| New | +$156K |
|
|
RPC
1979
Ridgepost Capital
RPC
$927M
| $145K | ﹤0.01% |
+11,484
| New | +$140K |
|
|
ENFN
1980
DELISTED
Enfusion, Inc.
ENFN
| $144K | ﹤0.01% |
+13,983
| New | +$135K |
|
1981
Nordic American Tanker
NAT
$1.37B
| $144K | ﹤0.01% |
57,408
+18,890
| +49% | +$58K |
|
1982
MaxCyte
MXCT
$116M
| $143K | ﹤0.01% |
34,462
+8,481
| +33% | +$32.1K |
|
|
LGF.A
1983
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $143K | ﹤0.01% |
16,775
+5,518
| +49% | +$43.5K |
|
1984
Mitek Systems
MITK
$762M
| $143K | ﹤0.01% |
+12,870
| New | +$120K |
|
1985
Portillo's
PTLO
$315M
| $143K | ﹤0.01% |
15,213
+5,006
| +49% | +$57.3K |
|
|
TRTX
1986
TPG RE Finance Trust
TRTX
$666M
| $143K | ﹤0.01% |
16,797
+5,527
| +49% | +$48.2K |
|
1987
Capricor Therapeutics
CAPR
$1.14B
| $142K | ﹤0.01% |
+10,317
| New | +$181K |
|
1988
PACS Group
PACS
$7.42B
| $142K | ﹤0.01% |
10,855
+3,391
| +45% | +$87K |
|
1989
SelectQuote
SLQT
$114M
| $142K | ﹤0.01% |
38,248
+12,955
| +51% | +$33.1K |
|
1990
Ardmore Shipping
ASC
$678M
| $142K | ﹤0.01% |
+11,678
| New | +$159K |
|
|
DHC
1991
Diversified Healthcare Trust
DHC
$2.26B
| $141K | ﹤0.01% |
61,516
+20,242
| +49% | +$59.6K |
|
|
ATXS
1992
DELISTED
Astria Therapeutics
ATXS
| $140K | ﹤0.01% |
+15,706
| New | +$167K |
|
1993
Stoke Therapeutics
STOK
$1.82B
| $139K | ﹤0.01% |
+12,626
| New | +$155K |
|
1994
Acco Brands
ACCO
$369M
| $138K | ﹤0.01% |
26,328
+8,663
| +49% | +$48.1K |
|
|
BLDP
1995
Ballard Power Systems
BLDP
$874M
| $138K | ﹤0.01% |
82,921
+43,998
| +113% | +$68.5K |
|
|
ESPR
1996
DELISTED
Esperion Therapeutics
ESPR
| $138K | ﹤0.01% |
62,549
+26,843
| +75% | +$62.6K |
|
1997
UroGen Pharma
URGN
$2B
| $137K | ﹤0.01% |
+12,895
| New | +$154K |
|
|
FNA
1998
DELISTED
Paragon 28, Inc.
FNA
| $137K | ﹤0.01% |
+13,272
| New | +$107K |
|
1999
Clear Channel Outdoor Holdings
CCO
$1.23B
| $136K | ﹤0.01% |
99,330
+32,683
| +49% | +$49.9K |
|
2000
Nuvation Bio
NUVB
$2.24B
| $136K | ﹤0.01% |
51,060
+16,801
| +49% | +$43.3K |
|
Similar funds
ProShare Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, ProShare Advisors held 2,321 positions worth $43.8B, up 7.2% from $40.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
ProShare Advisors deployed $2.92B of net new capital in Q4 2024, opening 255 new positions and adding to 1,689 existing holdings. Its largest new stake was Applovin: 338,942 shares worth $110M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was Walmart Inc, an estimated $285M trimmed.
- ProShare Advisors's largest Q4 2024 buy was Applovin: 338,942 shares worth $110M.
- ProShare Advisors added most to Apple in Q4 2024, an estimated $408M increase.
- ProShare Advisors's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $285M.
- ProShare Advisors fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $3.25M.
- ProShare Advisors's ten largest holdings make up 30% of its $43.8B portfolio in Q4 2024.
- ProShare Advisors opened 255 new positions and closed 50 in Q4 2024.
- ProShare Advisors's portfolio value rose 7.2% quarter-over-quarter to $43.8B.
Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.